TD Cowen analyst Ryan Langston raised the firm’s price target on Addus HomeCare (ADUS) to $139 from $135 and keeps a Buy rating on the shares. The firm updated its model following Q2 results as it now contemplates the additional revenues/EBITDA for Helping Hands and rate pickups in IL/TX.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADUS:
- Addus HomeCare Reports Strong Q2 2025 Growth
- Addus HomeCare Earnings Call Highlights Growth Amid Challenges
- Addus Homecare’s Strong Financial Performance and Strategic Growth Justify Buy Rating
- Addus HomeCare Reports Strong Q2 2025 Financial Results
- Addus HomeCare reports Q2 adjusted EPS $1.49, consensus $1.46